Menu Search
Equities

Concord Healthcare Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2453:HKG.HS

Concord Healthcare Group Co Ltd

Actions
  • Price (HKD)1.79
  • Today's Change0.13 / 7.83%
  • Shares traded640.00k
  • 1 Year change-78.12%
  • Beta--
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Concord Healthcare Group Co Ltd is a China-based company primarily engaged in providing medical services to cancer patients. The Company conducts its business through two segments. The Hospital Business segment serves cancer patients through self-operated medical institutions. The Medical Equipment, Software and Related Services segment is engaged in the sales and installation of medical equipment and software, management and technical support, and operating lease. The Company mainly conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)418.83m
  • Net income in HKD-495.45m
  • Incorporated2008
  • Employees573.00
  • Location
    Concord Healthcare Group Co LtdRoom 26A1-26A5, East Tower, Hanwei BuildBEIJING 100013ChinaCHN
  • Phone+86 1 059036688
  • Websitehttps://www.concordmedical.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.